Safety and efficacy of recombinant gamma interferon in the treatment of systemic sclerosis.

OBJECTIVE: To evaluate the safety and efficacy of recombinant gamma interferon (rIFN gamma) in the treatment of patients with systemic sclerosis. METHODS: Sixteen patients with systemic sclerosis were treated with r-IFN gamma, 60 micrograms m-2 (low dose, n = 10) and 150 micrograms m-2 (high dose, n...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Ann Rheum Dis
Main Authors: Vlachoyiannopoulos, P G, Tsifetaki, N, Dimitriou, I, Galaris, D, Papiris, S A, Moutsopoulos, H M
Formato: Artigo
Idioma:Inglês
Publicado em: BMJ Publishing Group 1996
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC1010296/
https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8984943/
https://ncbi.nlm.nih.govhttps://doi.org/10.1136/ard.55.10.761
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados